Share Search
Visit the Share Search
You are here:
Dechra buys Ampharco for $30m
29th Aug 2019 07:42
(Sharecast News) - Veterinary pharmaceuticals maker Dechra said it was buying Ampharmco (APC) and its US manufacturing site in Texas for $30m (£24.5m) in cash.
APC was founded in 1999 as a veterinary contract manufacturer specialising in companion animal products (CAP) and subsequently received FDA approval for two veterinary generic products, one of which is currently marketed by Dechra.
APC will also provide Dechra with an FDA registered facility to manufacture solid dose, liquids, creams and ointments, "which will significantly strengthen our manufacturing capabilities for the North American market", the company said on Thursday.
APC was founded in 1999 as a veterinary contract manufacturer specialising in companion animal products (CAP) and subsequently received FDA approval for two veterinary generic products, one of which is currently marketed by Dechra.
APC will also provide Dechra with an FDA registered facility to manufacture solid dose, liquids, creams and ointments, "which will significantly strengthen our manufacturing capabilities for the North American market", the company said on Thursday.